Kolling Institute News

Innovative test for kidney transplant complications

Page 3

Page 6

Page 11

Multi million dollar refurbishment for the Kolling

Accelerating pancreatic cancer research

Northern Sydney Local Health District

WWW.KOLLINGINSTITUTE.ORG.AU

MESSAGE FROM THE ACADEMIC DIRECTOR

I am pleased to share the latest Kolling newsletter, profiling the expert clinicians and researchers behind the scenes and their significant progress in recent months. It has been a big year for the institute, marked by our five-year research strategy, new collaborations, competitive grant success and growing activity across our discovery and translational research programs. With the research plan now being implemented, our focus is on translating this shared vision into meaningful outcomes. Developed through extensive consultation, the strategy will guide growth and innovation, support researchers to advance their work and expand access to high-value care. I look forward to seeing the breadth of our expertise showcased at the upcoming Kolling Research Symposium on November 24th. The full-day program in the Kolling auditorium will highlight our discovery, innovation and implementation strengths through engaging talks, interactive poster sessions and networking. It will be an opportunity to exchange ideas, spark collaborations and learn from colleagues across our research community. I am pleased to see that work will begin within months on an $8.5 million refurbishment of the Kolling building. The University of Sydney is contributing $7 million to the

upgrade, with the Northern Sydney Local Health District providing the balance of the funds. The project includes the multi- purpose Kolling Pavilion, contemporary learning spaces, a modern library, improved outdoor

Pleasingly, there has been progress across the institute with the Renal Research Lab exploring a potentially safer way to diagnose kidney transplant complications, and a policy roadmap calling for changes to osteoarthritis care, with nearly one billion people potentially affected by 2050. A large trial supported by Kolling clinician researchers found physiotherapist-led care significantly reduced emergency department waiting and treatment times for musculoskeletal conditions. Finally, the Living Longer, Living Better Showcase connected experts, donors, supporters and health professionals to explore healthy ageing, dementia prevention, medication management and the relationship between depression and dementia. Thank you to the NORTH Foundation for supporting this wonderful event. Together, these stories reflect our commitment to new knowledge and better care. Thank you to everyone for advancing our important collaborative work. Professor James Elliott

areas and seating, and an upgraded entry and foyer.

Encouragingly, it will enhance the experience of students and staff across the Royal North Shore Hospital campus. This newsletter highlights major grant success with Professor Gemma Figtree to lead a Centre of Research Excellence to reduce heart attacks. Her work is being supported by a $3 million National Health and Medical Research Council grant, while Professor Mark Molloy will drive research investigating rising rates of early- onset colorectal cancer through the ARTEMIS Centre of Research Excellence. In recent months we have welcomed two high profile researchers to the Kolling. Professor Marina Pajic has begun her new role as the Paul and Katherine Gobits (Koh) Chair of Pancreatic Cancer Research, bringing a determination to accelerate progress against this challenging cancer. Leading researcher Professor Jane Butler and her team relocated to Kolling and are driving their investigations into combined therapies for spinal cord injury.

2

KOLLINGNEWS | NOVEMBER 2026

Researchers develop test to identify the cause of kidney transplant complications

Renal Research Laboratory Team

“If we can identify the risks early, we can support targeted interventions and better transplant outcomes.” This valuable work has been recognised with Professor Pollock and Dr Wu recently receiving the International Basic and Translational Science Mentor- Mentee Award at the Transplantation Society International Congress in Sydney. Dr Wu also received a young investigator award for his contribution to the investigations at the recent Australia and New Zealand Society of Nephrology Meeting. The research is being led by Professor Pollock and Associate Professor Saad from the University of Sydney in collaboration with Professor Ewa Goldys and her team from the University of New South Wales.

Head of the Kolling’s Renal Research Laboratory Professor Carol Pollock said this exciting new technology provides clear information about kidney pathology by examining kidney cells in urine. Those comments have been supported by laboratory-based investigator Associate Professor Sonia Saad. “The use of urine as a source of kidney cells has a significant advantage compared to kidney biopsy in that it is non-invasive, carries no risk to the patient, and avoids inevitable hospital admission,” she said. Ongoing research by former PhD student and current postdoctoral clinician-researcher Dr Henry Wu is helping to advance the technology and incorporate it into patient care. “Having the ability to diagnose patients with a simple urine test represents a significant step forward for those with kidney transplantation,” he said.

We may soon have a safer approach to diagnosing the cause of kidney transplant complications following new research by the team from the Kolling Institute’s Renal Research Laboratory. Kidney transplantation is the preferred treatment for kidney failure, but it can lead to both short and long-term complications. With an estimated 30–50 per cent of transplant recipients experiencing complications, clinicians and researchers are calling for better ways to diagnose the cause of graft dysfunction. Currently, biopsy is the only validated way to identify the cause, but the procedure carries risks including bleeding, pain and hospitalisation. Encouragingly, researchers from the Kolling Institute and the University of New South Wales have now developed a urine test which can determine the causes of graft dysfunction without the risks of an invasive biopsy procedure.

3

WWW.KOLLINGINSTITUTE.ORG.AU

Professor Gemma Figtree

Kolling expertise secures funding for research into some of the biggest health challenges

The centre will investigate how blood biomarkers and advanced imaging can detect silent disease earlier. Importantly, researchers will work with the community to develop approaches that are accessible and equitable. “Our ultimate goal is to prevent heart attacks by identifying coronary artery disease while people still feel well and there is time to intervene,” said Professor Figtree.

“We now have highly effective treatments that can stabilise or even reverse the build-up of plaque in the coronary arteries,” she said. “However, these treatments are generally used most intensively after someone has had a heart attack or developed symptoms. “Our centre is seeking to shift this model from reacting to heart attacks to detecting and treating coronary artery disease before a potentially life-threatening attack.”

Internationally-recognised clinician researcher Professor Gemma Figtree will lead a Centre of Research Excellence to reduce heart attacks after securing a highly-competitive $3 million National Health and Medical Research Council grant. The research will aim to save lives by detecting and treating silent coronary artery disease, the underlying cause of most heart attacks. Professor Figtree said more than half of those who experience a heart attack have no symptoms, and some are not identified as high risk.

4

KOLLINGNEWS | NOVEMBER 2026

Understanding the increase in early-onset bowel cancer Fellow Kolling Institute and

Bowel Cancer Australia has committed $3 million through the NHMRC to establish the centre, supported by additional funding of $2.8 million from participating institutions and partners. ARTEMIS will be led by Associate Professor Dan Buchanan from The University of Melbourne, and will include a 22-member team across multiple disciplines, from six universities, four research institutes and four hospitals and health services.

Professor Molloy has established a bowel polyp biobank at the Kolling Institute and will contribute testing of the unique samples from people with early-onset bowel disease. His team’s expertise in the analysis of proteins and immune cells will help in the hunt for biological drivers of this form of cancer. “Collectively, the ARTEMIS team will aim to build new scientific understanding of why early onset colorectal cancer develops and establish clinical tools to help prevent and treat the disease better,” said Professor Molloy.

University of Sydney researcher Professor Mark Molloy will drive research into the rise of early- onset colorectal cancer as an investigator with the ARTEMIS Centre of Research Excellence. Early-onset colorectal cancer is a disease diagnosed in people under 50. The incidence has been rising rapidly in Australia since the 1990s, yet the cause of this rise is not understood. The centre will bring together patients and researchers from multiple institutes to study the genetic, environmental, microbial and immune factors contributing to the disease, and improve prevention, diagnosis and treatment.

Professor Mark Molloy

5

WWW.KOLLINGINSTITUTE.ORG.AU

Kolling refurbishment to create a vibrant, inclusive and modern learning environment

Work will begin within months on a multi-million dollar refurbishment program for

the Kolling building, enhancing education infrastructure and the

experience of students and staff across the Royal North Shore Hospital campus.

More than $8.5 million is being invested in the upgrade to the Kolling building-the academic and translational research hub for hundreds of staff and students across medicine, nursing and allied health. The University of Sydney is contributing $7 million to the refurbishment, with NSLHD providing the balance of the funds. To commence in January, the works will include the multi- purpose Kolling Pavilion, contemporary learning spaces and modern library, improved

including individual study areas, collaborative work tables and meeting rooms. Professor John Prins, Dean of the Faculty of Medicine and Health at the University of Sydney said the upgrade to the Kolling building will support interdisciplinary education and greatly improve facilities for students and staff.

outdoor spaces including new seating, and an upgraded entry and foyer. The Kolling Pavilion will provide a large meeting and education space which will also be used as an event facility. The library upgrade will deliver a range of modern, digitally enabled and accessible learning spaces,

6

KOLLINGNEWS | NOVEMBER 2026

“I would like to thank the University of Sydney for its generous investment which will transform part of the Kolling building and deliver significant new infrastructure to the campus. “Importantly, the works support the strategic direction of the district, the university, and the Kolling Institute, who are all committed to high- quality healthcare, inclusive education, and impactful research.”

“This exciting program of works will be purpose-built, providing modern, flexible and comfortable amenities, including both collaborative and private work spaces,” he said. “Importantly, the design will support research, teaching and mentoring, while promoting valuable collaboration. “The refurbishment will create a contemporary, professional and welcoming environment, encouraging informal learning, enhancing the university’s presence on the campus and supporting student wellbeing through access to purpose-built facilities.” NSLHD Chief Executive Anthony Schembri welcomed the refurbishment, saying it will foster a vibrant, inclusive and modern learning environment. “I am delighted to see this large- scale upgrading program take shape, and realise the significant benefits for students and staff on campus, as well as the broader research and health community,” he said.

The program of works is scheduled for completion by mid-2027.

7

WWW.KOLLINGINSTITUTE.ORG.AU

Nearly one billion people could be living with osteoarthritis by 2050

A new health policy roadmap has been published in The Lancet– calling on governments to shake- up care for debilitating osteoarthritis. Led by Professor Andrew Briggs from Curtin University, the research brought together experts from 18 countries, including Professors Lyn March and David Hunter, and Dr Saurab Sharma from the Kolling Institute and the University of Sydney. The roadmap calls for greater recognition of osteoarthritis in health policy, improved access to evidence-based, person centred care, and stronger prevention strategies. Researchers have identified three priorities: • To recognise osteoarthritis in national data and health policy • To scale up affordable, person-centred care, including better integration into primary and chronic disease care • To slow its growth by targeting excess body weight and joint injuries With one billion people likely to be living with osteoarthritis by 2050 and still no cure, researchers are calling for an escalation in high- quality, affordable care to dramatically reduce the burden of the condition. Lead author Professor Andrew Briggs said that health systems are not well placed to prevent and manage the rising burden of osteoarthritis, particularly in low and middle-income settings.

Professor Lyn March

Professor David Hunter

Co-senior author Professor David Hunter said there was a significant opportunity to shift osteoarthritis care away from low-value treatments towards prevention, early intervention and approaches that help people live well with the condition. “This starts with reframing how people think about and respond to osteoarthritis. Descriptions like ‘bone on bone’ or ‘wear and tear’ are outdated and often drive disengagement in care. Instead, reframing osteoarthritis symptoms as not inevitably progressive can better support people to participate in their care,” he said. “Although there are currently no disease-modifying drugs for osteoarthritis, we do know there are effective ways to help people manage osteoarthritis, but too many people are still receiving care that does not reflect the best available evidence.” Researchers say immediate action is needed to curb the escalation in osteoarthritis due to rising obesity rates, an ageing population and an increasing numbers of joint injuries.

“Osteoarthritis faces an image problem–it’s perceived as an unavoidable part of ageing with limited management options and remains largely invisible in national health policies,” he said. Those comments have been echoed by co-senior author Professor Lyn March, who says there needs to be a better understanding of the rising impact of osteoarthritis. “The global disability burden from osteoarthritis has increased by 65 per cent between 1990 and 2023–

one of the largest increases amongst the more than 350

conditions tracked in the Global Burden of Disease study,” she said. “We need health systems to recognise osteoarthritis as a major chronic disease. “This means greater efforts to measure and communicate the burden of osteoarthritis to policy makers so that care models can be scaled up, and people can access evidence-based care that is affordable and appropriate for their individual needs, irrespective of where they live.”

8

KOLLINGNEWS | NOVEMBER 2026

Kolling Institute strategy to escalate research impact and deliver world leading care

Associate Professor Naomi Hammond, Michael Nugent, Professor James Elliott, Nadia Levin and Professor Camille Raynes-Greenow

of healthcare through research, and delivering meaningful benefits

focus area of research, reflecting the opportunities to improve outcomes for patients through prevention and personalised treatment. As well as cancer, researchers will drive investigations into heart and kidney disease, chronic pain and neurological conditions, as well as musculoskeletal conditions. With a focus on discovery, innovation and implementation research, the strategy will strengthen community partnerships, expand collaboration across the institute and beyond, and improve workforce and environmental sustainability. NSLHD Chief Executive Anthony Schembri welcomed the framework saying we are building a culture of innovation that positions us as a leader in research excellence. “By bringing together researchers, clinicians, consumers, and partners, we are shaping the future

More than 150 people came together for the launch of the Kolling Institute’s Research Strategy 2026-2030, a roadmap to strengthen research expertise and expand access to high-value care. Developed through extensive consultation, the strategy provides a framework to guide future growth, innovation and impact. Academic Director Professor James Elliott unveiled the strategic blueprint saying it would build on the Kolling’s strengths while positioning the institute to respond to emerging healthcare challenges and opportunities. “This strategy will deliver tangible outcomes well beyond the next five years, escalating the impact of our work and strengthening our ability to drive high-quality research that improves the health of our local, national and international communities,” he said. A key feature is the inclusion of cancer as the institute’s fourth

for our community,” he said. The University of Sydney’s Professor Camille Raynes-

Greenow highlighted the discovery and translational research strength at the Kolling, and said a focus on innovation would help realise more effective treatments, better diagnostics and new models of care. “The strategy will ensure researchers are well positioned to advance their discoveries and broaden access to the latest medications, approaches and technologies,” she said. The strategy aligns with the goals of NSW Health, the Sydney North HealthCARE Innovation Precinct and the institute’s joint venture partners, ensuring research priorities maximise impact across the healthcare system.

9

WWW.KOLLINGINSTITUTE.ORG.AU

Trial confirms benefits of physiotherapist-led emergency care

“Our trial showed that changing who provides initial care to physiotherapists improved patient satisfaction, reduced the time patients spent in the emergency department, and saved hospitals money,” he said. Kolling Institute clinician researcher and co-author Professor Lisa Harvey said with emergency department crowding one of the greatest pressures facing the health system, this trial offers a promising way to create capacity without compromising patient safety or clinical outcomes.

Clinician researchers at the Kolling Institute supported a large-scale trial which found that physiotherapist-led care significantly reduced emergency department waiting and treatment times for people with musculoskeletal conditions. Close to 1500 patients were involved in the trial across five emergency departments, with patients receiving either standard care by emergency physicians or nurse practitioners-or physiotherapist-led care. Dubbed RESHAP-ED, the University of Sydney trial found there were significant improvements in the musculoskeletal care provided by physiotherapists, with better patient satisfaction and a reduction in the time spent in the emergency department. The research showed that patients who received the physio-led care spent an hour less in the emergency department, were assessed 40 minutes faster and were three times more likely to be seen within the recommended triage timeframes. Importantly, it found that the improvements did not compromise patient outcomes or safety. Chief Investigator, Associate Professor Gustavo Machado from the University’s Institute for Musculoskeletal Health said the research comes at an important time with musculoskeletal conditions leading to more than 1.3 million ED visits in Australia each

“These findings provide strong evidence for health services to consider physiotherapists as part of the frontline workforce for people with musculoskeletal conditions,” she said. This trial also demonstrated the financial benefits of the approach, with an economic evaluation confirming that physiotherapist-led care in emergency departments could save NSW hospitals $19 million a year. The research has been published in the Lancet.

Professor Lisa Harvey

year, which place demand on already crowded hospitals.

10

KOLLINGNEWS | NOVEMBER 2026

Landmark gift to drive new knowledge and reduce the toll of pancreatic cancer

Internationally-recognised investigator Professor Marina Pajic has begun her new role at the Kolling as the Paul and Katherine Gobits (Koh) Chair of Pancreatic Cancer Research, determined to accelerate research into one of Australia’s most challenging cancers. Her position follows a remarkable $11 million gift from Paul Gobits in memory of his wife Katherine. It is the largest individual philanthropic contribution to pancreatic cancer research in Australia. As a leader in pancreatic cancer research, Professor Pajic brings an outstanding record of achievement. She is a Snow Fellow, has authored more than 100 peer-reviewed publications, and secured more than $16 million in competitive research funding. Marina says the expertise of the Kolling researchers drew her to the institute. “There is an exceptional multidisciplinary team working here at the Kolling and across the Royal North Shore Hospital campus, who all share a commitment to improving the lives of patients,” she said.

Professor Marina Pajic

Pancreatic Cancer Research. Behind this position is a deeply personal story of love, loss and hope, and that makes the opportunity even more meaningful. “I am deeply grateful for Paul’s trust and am committed to ensuring this gift delivers the greatest possible impact for pancreatic cancer research and patients.”

“Pancreatic cancer is such a difficult disease, and real progress only happens when people come together across disciplines. “Knowing that the clinicians and researchers here have achieved the best outcomes for pancreatic cancer patients in Australia made the decision to join an easy one. “I feel incredibly honoured to be appointed as the inaugural Paul and Katherine Gobits (Koh) Chair of

Driving future research impact As the Paul and Katherine Gobits (Koh) Chair, Professor Pajic will help strengthen collaborations across the Kolling Institute, Sydney Medical School, health partners and the broader research community. “My hope is that we can change what a diagnosis of pancreatic cancer means for patients and their families,” she said. “Through this role, I want to bring together outstanding scientists, clinicians and emerging researchers to accelerate discoveries, develop better treatments and ultimately give more people the chance to live longer, healthier lives. That’s what drives me every day.”

11

WWW.KOLLINGINSTITUTE.ORG.AU

Emerging therapies offer hope following spinal cord injury

people with spinal cord injury significantly easier by improving function and movement.” With a large program of work ahead of her, Professor Buttler is looking to grow her team through new research students, while also establishing new collaborative opportunities. Her team is focusing on both fundamental and translational outcomes to support people with spinal cord injury. Professor Butler has more than 200 peer-reviewed publications and has attracted more than $27 million in funding over her career.

“Currently, we are seeing encouraging gains in function in feasibility studies using techniques like neurostimulation of the spinal cord or peripheral nerves, and acute intermittent hypoxia, involving controlled exposure to low oxygen. “There is a focus too on new molecules to facilitate regrowth of axons across the injury site– regarded as the holy grail. “There are promising signs with these techniques, but they will need to be thoroughly tested before they’re progressed. “My greatest hope is that we will be able to help make the lives of

Leading investigator Professor Jane Butler believes a combination of exciting new therapies will see the biggest gains for people living with a spinal cord injury. Professor Butler is internationally known for her research into spinal cord injury, specifically the neural control of respiration and neurorehabilitation after injury. Jane and her team of 12 recently relocated to the Kolling Institute after her appointment as a Senior Principal Research and SpinalCure Fellow. She said the Kolling is an outstanding research institute with some of the top spinal cord injury researchers in the world, and our team was keen to join forces with these researchers to work towards better outcomes for people with a spinal cord injury. “We are looking to bring some meaningful contributions and new collaborative opportunities to the existing spinal cord injury groups here at the Kolling,” she said. “It is an incredibly important time for spinal cord injury research, with new therapies offering hope for greater function and quality of life for those living with an injury. “These approaches need to be tested rigorously through clinical trials before they can be put into clinical practice, but I’m hopeful that some of these therapies will make a real difference to people’s lives.” Professor Butler believes a combination of different therapies to maximise any improvements will be the way of the future.

Professor Jane Butler

12

KOLLINGNEWS | NOVEMBER 2026

Makers and Shapers recognised

Associate Professor David Chan, Tom Lynch and Professor John Prins

Kolling award winners include: Thomas Lynch Research support excellence- individual For enabling arthritis and autoimmune research through

We would like to congratulate a collection of Kolling Institute researchers who have received a prestigious University of Sydney Makers and Shapers award. Professor John Prins, Dean of the University’s Faculty of Health and Medicine presented some awards during a Northern Sydney (Arabanoo) Precinct event at the Kolling. The awards recognise staff who are helping to drive the success of the faculty through their commitment, collaboration and

Ana Paula Moura Campos Carvalho Silva as part of the team award for Teaching Excellence OLET1510 Health Challenges: Sleep and Circadian Rhythms Teaching Team. The award recognises innovative sleep and circadian health education that demonstrates interdisciplinary reach and sustained impact on student learning. Kolling Academic Director Professor James Elliott and colleague A/Professor Marnee McKay received a research excellence team award for their MuscleMap work, recognising the outstanding impact of the international open-source research consortium that is advancing quantitative muscle imaging.

research support, trusted partnerships and a shared biobanking platform.

A/Professor David Chan and Dr Lisa Kouladjian O’Donnell as part of the leadership and collegiality team award for the Early-Mid Career Sub-Committee (FMH EMCR Sub-Committee) The award recognises their efforts to strengthen research culture by supporting early and mid-career researchers through advocacy, career development and cross- faculty collaboration.

impact. They have gone to recipients across a variety of fields, acknowledging their outstanding contribution.

13

WWW.KOLLINGINSTITUTE.ORG.AU

Kinga Szymaniak, Gurubhaskar Shivakumar, Erica Bell, Sue Kurrle, Sarah Hilmer, Lisa Harvey, Vicky Duong and Jillian Eyles

Researchers unveil the key to ageing well Clinical and research experts across the Kolling Institute passionately discussed the potential of their research to provide crucial new knowledge and effective treatments to support healthy ageing during a recent event. Hosted by the NORTH Foundation, more than 150 people came together for the Living Researchers detailed how their work is being translated into practical ways to help maintain health and independence. NORTH Foundation CEO Gil Lorquet thanked the many people who attended the showcase, saying it is at events like this

“We are proud of the strength of our research community and grateful to the NORTH Foundation for its ongoing partnership in helping us turn discovery into impact,” he said. “Together with our community partners and generous donors, we are translating research into real-world benefit and building a healthier future for communities locally, nationally and globally. We are grateful for their crucial backing.”

where we provide an insight into the talented people behind our leading healthcare and valuable research. “There is a wealth of expertise across the Kolling and we are delighted to connect members of the community with researchers to help them pursue ideas with the potential to transform lives,” he said. The Kolling’s Academic Director Professor James Elliott said the showcase highlighted the power of collaboration to advance research and improve health outcomes.

Longer, Living Better showcase, including donors, supporters and health professionals. The event explored the latest research into healthy-ageing, dementia prevention, medication management, therapeutic exercise, evidence-based osteoarthritis care, and the relationship between depression and dementia. The presenters focused on maintaining health, strength, mobility and quality of life through evidenced-based approaches.

To support our researchers, contact our fundraising partner the NORTH Foundation.

14

KOLLINGNEWS | NOVEMBER 2026

Life can change in an instant

Support your local hospitals this Christmas Your donation to the Christmas Appeal will support world-class healthcare and research across the district.

Donate

PODCAST PODCAST TOMORROW’S MEDICINE TODAY

Discover the latest breakthroughs in medical research from Australia’s leading experts.

Each episode explores how science is transforming healthcare- offering hope, innovation and real-world solutions for patients and professionals alike.

Listen today

Professor James Elliot Host

A/Professor Matt Doane Host

Available on the NSLHD website and Spotify

A collaboration between NSLHD and the Kolling Institute

Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 Page 13 Page 14 Page 15 Page 16

www.nslhd.health.nsw.gov.au

Made with FlippingBook - professional solution for displaying marketing and sales documents online